Search for: "Sanofi-Aventis U.S. LLC"
Results 41 - 60
of 72
Sorted by Relevance
|
Sort by Date
9 Nov 2020, 3:00 am
Sanofi-Aventis U.S. [read post]
9 Nov 2020, 3:00 am
Sanofi-Aventis U.S. [read post]
20 May 2011, 8:53 am
Sanofi-Aventis U.S. [read post]
24 Oct 2019, 9:24 am
A generic company recently invalidated a number of patents covering Lantus®—an insulin product that nets Sanofi-Aventis $15 million per day and has been the subject of numerous price hikes that far exceed inflation. [read post]
2 Jan 2015, 10:15 am
Restani, siting by designation from the U.S. [read post]
15 May 2011, 2:54 pm
Karst – Last week, the Federal Trade Commission (“FTC”) announced that the Commission’s Bureau of Competition (“Bureau”) sent letters (here, here, and here) to Sanofi-Aventis U.S. [read post]
15 Apr 2021, 10:51 am
Sanofi-Aventis U.S. [read post]
25 Jul 2013, 11:43 am
Lucier was a thalidomide case against GSK, SmithKline Beecham, Sanofi-Aventis, Grunethal, and others and was originally filed in Pennsylvania state court. [read post]
25 Aug 2017, 7:02 am
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
25 Aug 2017, 7:02 am
” The allegations against Mylan were brought to court by pharmaceutical manufacturer Sanofi-Aventis US LLC under a provision of the False Claims Act that permits private qui tam whistleblowers to sue alleged wrongdoers on behalf of the federal government. [read post]
10 Jul 2011, 11:29 pm
The committee is seeking documents and information from Amphastar Pharmaceuticals, Momenta Pharmaceuticals, Siegfried USA Inc., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]
10 Jun 2010, 3:58 am
Kappos (Patent Docs) Products Allegra (Fexofenadine) - US: Patent infringement complaint following a Paragraph IV certification: Sanofi-Aventis U.S. [read post]
29 Jun 2011, 3:34 am
Cipla (Spicy IP) Effexor (Venlafaxine) – US: Intellipharmaceutics announces settlement for its generic version of Effexor (GenericsWeb) Eloxatin (Oxaliplatin) – US: Patent infringement complaint in response to Para IV certification: Sanofi-Aventis U.S. [read post]
10 Apr 2015, 3:00 am
” Here, the State of West Virginia, by its Attorney General alleged that the defendants Bristol-Meyers Squibb Company, Sanofi-Aventis U.S., LLC, Sanofi U.S. [read post]
1 Mar 2016, 1:32 pm
Sanofi-Aventis U.S., LLC, No. 13-17390, slip op. [read post]
25 Jan 2009, 2:36 pm
The last big pharmaceutical industry acquisition came in August 2004, when Paris-based Sanofi-Synthelabo acquired Aventis SA of Strasburg, France, for $64.4 billion to create Sanofi Aventis SA, France's largest drugmaker. [read post]
25 Aug 2010, 12:37 am
U.S. [read post]
5 Feb 2012, 8:04 am
See Sanofi-Aventis chemist admits trade secret theft. [read post]
22 Feb 2012, 7:37 am
GmbH and Sanofi-aventis v. [read post]
4 Nov 2019, 5:01 am
Sanofi-Aventis U.S. [read post]
